GLAUKOS CORP (GKOS) Fundamental Analysis & Valuation

NYSE:GKOS • US3773221029

Current stock price

121.65 USD
-0.46 (-0.38%)
At close:
121.65 USD
0 (0%)
After Hours:

This GKOS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GKOS Profitability Analysis

1.1 Basic Checks

  • GKOS had negative earnings in the past year.
  • GKOS had a negative operating cash flow in the past year.
  • In the past 5 years GKOS always reported negative net income.
  • In the past 5 years GKOS reported 4 times negative operating cash flow.
GKOS Yearly Net Income VS EBIT VS OCF VS FCFGKOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • GKOS has a Return On Assets of -21.01%. This is comparable to the rest of the industry: GKOS outperforms 48.66% of its industry peers.
  • The Return On Equity of GKOS (-28.60%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.01%
ROE -28.6%
ROIC N/A
ROA(3y)-16.78%
ROA(5y)-12.99%
ROE(3y)-25.62%
ROE(5y)-20.8%
ROIC(3y)N/A
ROIC(5y)N/A
GKOS Yearly ROA, ROE, ROICGKOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • GKOS's Gross Margin of 77.97% is amongst the best of the industry. GKOS outperforms 89.84% of its industry peers.
  • GKOS's Gross Margin has improved in the last couple of years.
  • GKOS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y5.66%
GKOS Yearly Profit, Operating, Gross MarginsGKOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. GKOS Health Analysis

2.1 Basic Checks

  • GKOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GKOS has been increased compared to 1 year ago.
  • Compared to 5 years ago, GKOS has more shares outstanding
  • The debt/assets ratio for GKOS is higher compared to a year ago.
GKOS Yearly Shares OutstandingGKOS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
GKOS Yearly Total Debt VS Total AssetsGKOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 17.22 indicates that GKOS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of GKOS (17.22) is better than 93.58% of its industry peers.
  • A Debt/Equity ratio of 0.10 indicates that GKOS is not too dependend on debt financing.
  • GKOS has a Debt to Equity ratio of 0.10. This is in the better half of the industry: GKOS outperforms 65.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 17.22
ROIC/WACCN/A
WACC8.9%
GKOS Yearly LT Debt VS Equity VS FCFGKOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • GKOS has a Current Ratio of 4.69. This indicates that GKOS is financially healthy and has no problem in meeting its short term obligations.
  • GKOS's Current ratio of 4.69 is fine compared to the rest of the industry. GKOS outperforms 71.66% of its industry peers.
  • GKOS has a Quick Ratio of 4.06. This indicates that GKOS is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 4.06, GKOS is doing good in the industry, outperforming 72.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.69
Quick Ratio 4.06
GKOS Yearly Current Assets VS Current LiabilitesGKOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. GKOS Growth Analysis

3.1 Past

  • GKOS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.63%, which is quite impressive.
  • The Revenue has grown by 32.33% in the past year. This is a very strong growth!
  • The Revenue has been growing by 17.66% on average over the past years. This is quite good.
EPS 1Y (TTM)52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)32.33%
Revenue growth 3Y21.5%
Revenue growth 5Y17.66%
Sales Q2Q%35.66%

3.2 Future

  • The Earnings Per Share is expected to grow by 47.14% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, GKOS will show a very strong growth in Revenue. The Revenue will grow by 24.73% on average per year.
EPS Next Y35.35%
EPS Next 2Y56.45%
EPS Next 3Y54.97%
EPS Next 5Y47.14%
Revenue Next Year22.65%
Revenue Next 2Y25.02%
Revenue Next 3Y27.12%
Revenue Next 5Y24.73%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GKOS Yearly Revenue VS EstimatesGKOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
GKOS Yearly EPS VS EstimatesGKOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

1

4. GKOS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GKOS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GKOS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GKOS Price Earnings VS Forward Price EarningsGKOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GKOS Per share dataGKOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GKOS's earnings are expected to grow with 54.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.45%
EPS Next 3Y54.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GKOS Dividend Analysis

5.1 Amount

  • No dividends for GKOS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GKOS Fundamentals: All Metrics, Ratios and Statistics

GLAUKOS CORP

NYSE:GKOS (4/22/2026, 7:00:00 PM)

After market: 121.65 0 (0%)

121.65

-0.46 (-0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)04-29
Inst Owners100.65%
Inst Owner Change-0.07%
Ins Owners3.14%
Ins Owner Change-1.38%
Market Cap7.07B
Revenue(TTM)507.44M
Net Income(TTM)-187.69M
Analysts83.64
Price Target137.63 (13.14%)
Short Float %5.55%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.39%
Min EPS beat(2)-39.91%
Max EPS beat(2)39.14%
EPS beat(4)3
Avg EPS beat(4)12.06%
Min EPS beat(4)-39.91%
Max EPS beat(4)39.14%
EPS beat(8)5
Avg EPS beat(8)8.75%
EPS beat(12)7
Avg EPS beat(12)5.88%
EPS beat(16)10
Avg EPS beat(16)1.95%
Revenue beat(2)2
Avg Revenue beat(2)4.86%
Min Revenue beat(2)2.88%
Max Revenue beat(2)6.84%
Revenue beat(4)4
Avg Revenue beat(4)4.27%
Min Revenue beat(4)2.01%
Max Revenue beat(4)6.84%
Revenue beat(8)8
Avg Revenue beat(8)4.29%
Revenue beat(12)12
Avg Revenue beat(12)4.22%
Revenue beat(16)16
Avg Revenue beat(16)4.37%
PT rev (1m)0.11%
PT rev (3m)4.94%
EPS NQ rev (1m)-4.68%
EPS NQ rev (3m)-49.25%
EPS NY rev (1m)-2.27%
EPS NY rev (3m)-90.55%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)3.96%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.92
P/FCF N/A
P/OCF N/A
P/B 10.77
P/tB 15.79
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS8.74
BVpS11.3
TBVpS7.71
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -21.01%
ROE -28.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.97%
FCFM N/A
ROA(3y)-16.78%
ROA(5y)-12.99%
ROE(3y)-25.62%
ROE(5y)-20.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y5.66%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.32%
Cap/Sales 4.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.69
Quick Ratio 4.06
Altman-Z 17.22
F-Score3
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)42.14%
Cap/Depr(5y)76.69%
Cap/Sales(3y)4.29%
Cap/Sales(5y)7.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y35.35%
EPS Next 2Y56.45%
EPS Next 3Y54.97%
EPS Next 5Y47.14%
Revenue 1Y (TTM)32.33%
Revenue growth 3Y21.5%
Revenue growth 5Y17.66%
Sales Q2Q%35.66%
Revenue Next Year22.65%
Revenue Next 2Y25.02%
Revenue Next 3Y27.12%
Revenue Next 5Y24.73%
EBIT growth 1Y19.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.33%
EBIT Next 3Y75.68%
EBIT Next 5YN/A
FCF growth 1Y42.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.88%
OCF growth 3YN/A
OCF growth 5YN/A

GLAUKOS CORP / GKOS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GLAUKOS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to GKOS.


What is the valuation status for GKOS stock?

ChartMill assigns a valuation rating of 1 / 10 to GLAUKOS CORP (GKOS). This can be considered as Overvalued.


Can you provide the profitability details for GLAUKOS CORP?

GLAUKOS CORP (GKOS) has a profitability rating of 2 / 10.


Can you provide the financial health for GKOS stock?

The financial health rating of GLAUKOS CORP (GKOS) is 5 / 10.